Updated: January 13, 2021 03:21 PM
Created: January 12, 2021 06:32 PM
FARMINGTON, N.M.— One of the goals for 2021 is to reduce COVID-related hospitalizations. Doctors from San Juan Regional Medical Center said that's where monoclonal antibody infusion therapy comes in.
“Monoclonal antibody therapy refers to the infusion of laboratory-made protein that mimic the immune system's ability to fight off harmful antigens, like viruses for example," said Dr. Brad Greenberg, an emergency physician at SJRMC.
The treatment is for patients who are not in the hospital, but have a mild to moderate coronavirus infection. San Juan Regional Medical Center will now be offering the infusion to patients. Two medications have been approved so far for this infusion.
“The Eli Lilly product is called Bamlanivimab and then there is another product made by Regeneron, which is Casirivimab and combined with another medication called Imdevimab,” said Dr. Greenberg.
The medication names may sound like a mouthful, but health officials hope they can help reduce COVID-19 hospitalizations—especially for those who already have underlying health conditions and may develop more severe COVID-19 symptoms.
“If anyone thinks that they were recently diagnosed with COVID-19 and feel like they would be a candidate for this therapy, definitely contact your provider," said Dr. Greenberg.
Health officials said people should contact their provider as soon as possible, at least 10 days before the onset of symptoms.
Copyright 2021 - KOB-TV LLC, A Hubbard Broadcasting Company